These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 11422905

  • 1. Possible involvement of IL-12 in reovirus type-2-induced diabetes in newborn DBA/1 mice.
    Hayashi T, Morimoto M, Iwata H, Onodera T.
    Scand J Immunol; 2001 Jun; 53(6):572-8. PubMed ID: 11422905
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Elimination of CD4+ CD25+ regulatory T cells breaks down reovirus type 2-triggered and CpG ODN-induced prolonged mild autoimmune insulitis in DBA/1 mice.
    Hayashi T, Hasegawa K, Sasaki Y, Onodera T.
    Scand J Immunol; 2006 Feb; 63(2):116-24. PubMed ID: 16476010
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. CpG oligodeoxynucleotides accelerate reovirus type 2-triggered insulitis in DBA/1 suckling mice.
    Hayashi T, Yoshinaka K, Hasegawa K, Maeda K, Onodera T.
    Int J Exp Pathol; 2002 Oct; 83(5):217-23. PubMed ID: 12641818
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prevention of reovirus type 2-induced diabetes-like syndrome in DBA/1 suckling mice by treatment with antibodies against intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1.
    Hayashi T, Yamamoto S, Onodera T.
    Int J Exp Pathol; 1995 Dec; 76(6):403-9. PubMed ID: 8652360
    [Abstract] [Full Text] [Related]

  • 11. Role of interleukin-2 in pancreatic islet-cell destruction in reovirus type 2-infected DBA/1 suckling mice.
    Hayashi T, Iwata H, Onodera T.
    J Comp Pathol; 1999 Apr; 120(3):313-20. PubMed ID: 10213676
    [Abstract] [Full Text] [Related]

  • 12. IL-18 inhibits diabetes development in nonobese diabetic mice by counterregulation of Th1-dependent destructive insulitis.
    Rothe H, Hausmann A, Casteels K, Okamura H, Kurimoto M, Burkart V, Mathieu C, Kolb H.
    J Immunol; 1999 Aug 01; 163(3):1230-6. PubMed ID: 10415018
    [Abstract] [Full Text] [Related]

  • 13. Systemic administration of IL-18 promotes diabetes development in young nonobese diabetic mice.
    Oikawa Y, Shimada A, Kasuga A, Morimoto J, Osaki T, Tahara H, Miyazaki T, Tashiro F, Yamato E, Miyazaki J, Saruta T.
    J Immunol; 2003 Dec 01; 171(11):5865-75. PubMed ID: 14634096
    [Abstract] [Full Text] [Related]

  • 14. Interleukin 12 mRNA expression in islets correlates with beta-cell destruction in NOD mice.
    Rabinovitch A, Suarez-Pinzon WL, Sorensen O.
    J Autoimmun; 1996 Oct 01; 9(5):645-51. PubMed ID: 8933280
    [Abstract] [Full Text] [Related]

  • 15. Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes.
    Trembleau S, Penna G, Gregori S, Gately MK, Adorini L.
    Eur J Immunol; 1997 Sep 01; 27(9):2330-9. PubMed ID: 9341777
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity.
    Piccotti JR, Chan SY, Goodman RE, Magram J, Eichwald EJ, Bishop DK.
    J Immunol; 1996 Sep 01; 157(5):1951-7. PubMed ID: 8757314
    [Abstract] [Full Text] [Related]

  • 18. Protection against autoimmune diabetes with oral insulin is associated with the presence of IL-4 type 2 T-cells in the pancreas and pancreatic lymph nodes.
    Ploix C, Bergerot I, Fabien N, Perche S, Moulin V, Thivolet C.
    Diabetes; 1998 Jan 01; 47(1):39-44. PubMed ID: 9421372
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.
    Rothe H, O'Hara RM, Martin S, Kolb H.
    Diabetologia; 1997 Jun 01; 40(6):641-6. PubMed ID: 9222642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.